|
Variables
|
Number (n = 31)
|
|---|
|
Gender, male (%)
|
14 (45.2%)
|
|
Agea
|
56.00 (52.00, 64.00)
|
|
MG
|
4 (12.9%)
|
|
Tumor size (cm)a
|
5.75 (4.50, 8.88)
|
|
First-line treatment
|
|
VATS
|
17 (54.8%)
|
|
Sternotomy
|
8 (25.8%)
|
|
Chemotherapy
|
6 (19.4%)
|
|
Mosaoka-Koga stage
|
|
I
|
11 (35.5%)
|
|
II
|
7 (22.6%)
|
|
III
|
5 (16.1%)
|
|
IV
|
8 (25.8%)
|
|
WHO classification
|
|
A
|
4 (12.9%)
|
|
AB
|
7 (22.6%)
|
|
B1
|
2 (6.5%)
|
|
B2
|
9 (29.0%)
|
|
B3
|
1 (3.2%)
|
|
Carcinoma
|
8 (25.8%)
|
- Note.—Unless otherwise indicated, data are the number of patients, with the percentage in parentheses. VATS = video-assisted thoracic surgery
- a Data are the median, with the first and third quartile in parentheses
